Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation

Gene Ther. 2004 Jun;11(12):1019-22. doi: 10.1038/sj.gt.3302273.

Abstract

Graft-versus-host disease, resulting from the T cells present in allogeneic hematopoietic stem cell (HSC) inoculums, can potentially be treated if a suicide gene has been introduced into the donor T cells. However, the diversity and functionality of the transfused T-cell population, including EBV- (EBV-T) and CMV-specific (CMV-T) CD8+ T cells, which are particularly important for immunosuppressed individuals undergoing HSC transplants, are often modified by the gene transfer protocol. Here, we show that following polyclonal T-cell activation, EBV-T and CMV-T cells are preferentially transduced by oncoretroviral vectors, as compared to the bulk CD8+ T-cell population. This preferential transduction is associated with higher surface levels of PiT-2, the receptor for the amphotropic envelope with which the virions are pseudotyped. Moreover, EBV-T and CMV-T cells proliferate more extensively as compared to bulk CD8+ T cells. Thus, retroviral-mediated transduction can be biased toward a given antigenic specificity, even under conditions of polyclonal stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology*
  • Cell Division
  • Cytomegalovirus / immunology*
  • Epitopes
  • Genetic Therapy / methods*
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / therapy
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Immunotherapy
  • Lymphocyte Activation
  • Lymphocyte Count
  • Retroviridae / genetics*
  • Transduction, Genetic / methods*

Substances

  • Epitopes